Tag: CBT > Cannabis Rescheduling: Page 2

Wyoming

Wyoming Rejects Trump Administration’s Schedule III Cannabis Listing; Keeps It Schedule I

Wyoming Attorney General Keith G. Kautz announced that he won’t loosen restrictions on cannabis after there was little public interest in doing so.

July 8, 2026

Cannabis Rescheduling

Prohibitionists Punch Back at Cannabis Rescheduling Hearing

Anti-rescheduling participants who oppose the Schedule III proposal attempt to expose flaws in a scientific and medical evaluation and discredit DEA witnesses.

July 1, 2026

Cannabis Rescheduling

DEA Comes Out Swinging in Cannabis Rescheduling Hearing

The government argued in support of currently accepted medical use; anti-rescheduling parties attempted to poke holes in the Schedule III recommendation.

June 30, 2026

Cannabis Rescheduling

DEA Plans to Call Pain Management Doctor, FDA Official to Testify at Cannabis Reschedule Hearing

The Drug Enforcement Administration filed a prehearing statement summarizing its two proposed witnesses’ testimony.

June 26, 2026

Massachusetts

MariMed Submits DEA Registration Applications for State-Licensed Medicreschedal Cannabis Businesses

The registration aligns with the federal Schedule III classification, which grants safe harbor to licensed operators and removes Section 280E tax restrictions.

June 25, 2026

Cannabis Rescheduling

DEA Judge Sets Cannabis Hearing Schedule, Won’t Consider More Participants

The administrative law judge declined to consider pleas from non-parties to participate in the rescheduling hearing for the proposed Schedule III rule.

June 25, 2026

Cannabis Rescheduling

Should DEA’s One-Sided Cannabis Rescheduling Hearing Be Reason for Concern?

The government may lack a sufficient administrative record to defend a Schedule III decision in judicial review without any pro-rescheduling participants.

June 24, 2026

Cannabis Rescheduling

Feds Haven’t Provided ‘Clear Guidance, Feedback’ to Ohio on Cannabis Rescheduling

The state’s Division of Cannabis Control ‘doesn’t have a lot of great answers’ for its dual-licensed operators, the department’s legal counsel says.

June 18, 2026

Cannabis Rescheduling

Anti-Rescheduling Parties Ask Court to Stay Schedule III Cannabis Order

A national drug screening association and a private pharmaceutical cannabinoid development company argue they’ll suffer irreparable harm.

June 11, 2026

Cannabis Rescheduling

5 ‘Aggrieved Persons’ Sue Trump, DOJ Over Cannabis Rescheduling Order

A substance abuse recovery clinic, two doctors, a victims’ advocacy organization and a pharmaceutical company claim the order was unlawful.

June 1, 2026

Finance

Verano Announces 1-for-5 Reverse Stock Split to Prepare for Prospective US Stock Listing

The reverse stock split builds on prior strategic initiatives the company has executed to prepare for future growth and U.S. capital markets opportunities.

June 1, 2026

Cannabis Tax Law

7 House Democrats Demand IRS, Treasury Provide 280E Cannabis Guidance

The U.S. representatives sent a letter urging ‘clear, timely guidance’ for state-licensed medical businesses following the DOJ’s rescheduling order.

May 29, 2026